Compare RRX & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | RRX | GMED |
|---|---|---|
| Founded | 1955 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 11.7B |
| IPO Year | 1987 | 2012 |
| Metric | RRX | GMED |
|---|---|---|
| Price | $154.29 | $91.64 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 15 |
| Target Price | ★ $169.80 | $95.92 |
| AVG Volume (30 Days) | 611.0K | ★ 1.4M |
| Earning Date | 02-04-2026 | 02-24-2026 |
| Dividend Yield | ★ 0.88% | N/A |
| EPS Growth | 22.48 | ★ 358.86 |
| EPS | ★ 3.87 | 3.08 |
| Revenue | ★ $5,872,300,000.00 | $2,769,804,000.00 |
| Revenue This Year | N/A | $17.65 |
| Revenue Next Year | $3.67 | $8.37 |
| P/E Ratio | $41.07 | ★ $30.73 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $90.56 | $51.79 |
| 52 Week High | $167.78 | $101.40 |
| Indicator | RRX | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 53.97 | 53.16 |
| Support Level | $151.40 | $91.10 |
| Resistance Level | $162.20 | $95.22 |
| Average True Range (ATR) | 5.85 | 3.35 |
| MACD | 0.23 | -0.18 |
| Stochastic Oscillator | 48.92 | 33.11 |
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.